ArticleOpen journal of social sciences2023
Breast Cancer Survival Rates in Costa Rican Social Security Fund Patients: A 5-Year Analysis.
Article in Open journal of social sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Background: Breast cancer is a significant cause of mortality among women worldwide. While there has been increasing focus on breast cancer screening in countries of Central American, limited recent information is available providing national survival rates. This study aimed to determine the 5-year survival rate for women with breast cancer who received treatment through the Costa Rican Caja Costarricense del Seguro Social (CCSS) between 2008 and 2012. Methods: A retrospective cohort study was conducted of women with breast cancer who received treatment through the CCSS between 2008 and 2012. The Kaplan-Meier (KP) method was used to calculate survival rates, and univariate and multivariate Cox regression analyses were conducted to identify factors associated with survival. Results: The KP method showed a gradual decline in survival over time, declining from 94.4% at 12 months to 76.3% at 5 years. The 5-year survival rates were highest in early-stage (stage I and IIA) and lowest in stage IV; five-year mortality rate among women diagnosed with stage IIIB cancer was four times higher than for those with stage IIB cancer and half that of women diagnosed with metastatic disease. Patients who underwent conservative or radical surgery had decreased risks of mortality compared to those who did not receive surgery. Multivariate analysis identified advanced stage, older age, multifocal tumors, poorly differentiated tumors, triple-negative tumors, and the absence of surgery as significant risk factors for mortality. Conclusion: The 5-year survival rate for women with breast cancer who received treatment through the CCSS between 2008 and 2012 is encouraging, but improvement is needed in early diagnosis and treatment, particularly for women with advanced stages of breast cancer. These findings highlight the need for continued efforts to improve breast cancer detection and treatment in Costa Rica.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.